EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

High-Sensitivity C-Reactive Protein Levels in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), Metabolic Alcohol-Associated Liver Disease (MetALD), and Alcoholic Liver Disease (ALD) with Metabolic Dysfunction

Seong-Uk Baek iD, Jin-Ha Yoon

Biomolecules · 18.11.2024 · 14 (11) · 1468

DOI: 10.3390/biom14111468 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, online erschienen am 18.11.2024. Verfasst von Seong-Uk Baek und 1 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School, Yonsei University College of Medicine, Seoul 03722, Republic of Korea. Hauptthemen laut MEDLINE: C-Reactive Protein, Liver Diseases, Alcoholic. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metabolic dysfunction-associated steatotic liver disease (MASLD) is a recently introduced term for steatotic liver disease (SLD). Although the inflammatory process is central to the pathogenesis of SLD, research investigating the differences in systemic inflammation across various SLD subtypes as well as sex differences is limited. This population-based, cross-sectional study investigated the association between SLD subtypes and high-sensitivity C-reactive protein (hs-CRP) levels among Korean adults (N = 20,141; mean age: 50.8 ± 16.7 years). The participants were classified into five groups that included no SLD, MASLD, metabolic alcohol-associated liver disease (MetALD), alcoholic liver disease with metabolic dysfunction (ALD with MD), and other SLDs. The median (Q1, Q3) value of the hs-CRP level was 0.54 mg/L (0.33, 1.04). Among men, compared to levels in the no SLD group, the MASLD, MetALD, and ALD with MD groups were associated with 41.9% (95% confidence interval [CI]: 35.1–49.1%), 46.8% (95% CI: 35.0–59.6%), and 51.8% (95% CI: 30.0–77.2%) increases in hs-CRP levels, respectively. The association between SLD subtypes and hs-CRP levels was stronger among women, and compared to the levels in the no SLD group, the MASLD, MetALD, and ALD with MD groups were associated with 81.5% (95% CI: 73.6–89.8%), 84.3% (95% CI: 58.1–114.8%), and 98.2% (95% CI: 38.0–184.8%) increases in hs-CRP levels, respectively. In conclusion, our findings indicate a varying profile of systemic inflammation across SLD subtypes, with more pronounced increases in hs-CRP levels in women with SLDs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

C-Reactive ProteinLiver Diseases, AlcoholicHumansMaleFemaleMiddle AgedAdultCross-Sectional StudiesAgedFatty LiverRepublic of KoreaBiomarkers

Stichwörter der Autor:innen

high-sensitivity C-reactivity proteininflammationinflammatory markerliver diseasemetabolic diseaseoxidative stress

Substanzen

C-Reactive ProteinBiomarkers

Autor:innen und Institutionen

  • Graduate School, Yonsei University College of Medicine, Seoul 03722, Republic of Korea.
  • Department of Preventive Medicine, Yonsei University College of Medicine, Seoul 03722, Republic of Korea.
  • The Institute for Occupational Health, Yonsei University College of Medicine, Seoul 03722, Republic of Korea.

ORCID-Profile: Seong-Uk Baek

Zitieren

APA

Baek, S. U., & Yoon, J. H. (2024). High-Sensitivity C-Reactive Protein Levels in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), Metabolic Alcohol-Associated Liver Disease (MetALD), and Alcoholic Liver Disease (ALD) with Metabolic Dysfunction. Biomolecules, 14(11), 1468. https://doi.org/10.3390/biom14111468

Vancouver

Baek SU, Yoon JH. High-Sensitivity C-Reactive Protein Levels in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), Metabolic Alcohol-Associated Liver Disease (MetALD), and Alcoholic Liver Disease (ALD) with Metabolic Dysfunction. Biomolecules. 2024;14(11):1468. doi:10.3390/biom14111468

BibTeX
@article{Baek2024,
  author = {Baek, Seong-Uk and Yoon, Jin-Ha},
  title = {High-Sensitivity C-Reactive Protein Levels in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), Metabolic Alcohol-Associated Liver Disease (MetALD), and Alcoholic Liver Disease (ALD) with Metabolic Dysfunction},
  journal = {Biomolecules},
  year = {2024},
  volume = {14},
  number = {11},
  pages = {1468},
  doi = {10.3390/biom14111468}
}
Kostenlos starten →